News Daily News FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels Michael O'Riordan December 22, 2021
News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021
News Daily News The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI Caitlin E. Cox December 09, 2021
News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021
News Conference News TCT 2021 Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support Caitlin E. Cox November 11, 2021
News Daily News DNRs Muddy Waters in Acute MI Care as Palliative Services Fall Short Yael L. Maxwell October 27, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Daily News Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest Caitlin E. Cox July 19, 2021
News Daily News First PCIs Preceded by Many Modifiable Risk Factors: Registry Data L.A. McKeown June 16, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News Hospitalization for HF After Acute MI More Common in Women Than Men L.A. McKeown January 15, 2021